Author

D. Watt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1

Frequent Co-Authors

B. M. Evers· 1 shared C. I. Wittke· 1 shared C. Liu· 1 shared D. Athineos· 1 shared E. C. Cheung· 1 shared H. L. Weiss· 1 shared J. Johnson· 1 shared K. Blyth· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. M. Evers

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

p53 and TIGAR promote redox control to protect against metabolic dysfunction-associated steatohepatitis

C. I. Wittke, E. C. Cheung, D. Athineos, N. Clements, L. Butler, M. Hughes, V. Morrison, D. Watt, K. Blyth, K. Vousden, T. J. Humpton

This study shows that p53 and TIGAR protect against MASH by controlling redox balance, preventing ROS accumulation, fibrosis, and inflammation.

bioRxiv · May 20, 2024Cancer Biology

Induction of AMPK activation by N,N-Diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers

J. Johnson, P. Rychahou, V. M. Sviripa, H. L. Weiss, C. Liu, D. Watt, B. M. Evers

This paper tests the effects of FND-4b, a novel AMPK activator, on breast cancer cell proliferation and apoptosis, finding it reduces growth and increases apoptosis in both estrogen-receptor positive and triple-negative breast cancer cells.

bioRxiv · Dec 6, 2018Cancer Biology